Publicacións en colaboración con investigadores/as de Universidade da Coruña (159)

2024

  1. Cyclosporin A as an Add-On Therapy to a Corticosteroid-Based Background Treatment in Patients with COVID-19: A Multicenter, Randomized Clinical Trial

    Journal of Clinical Medicine, Vol. 13, Núm. 17

  2. Demographic transition and hospital admissions in Spanish centenarians, 2004–2020: Geographical variations and sex-related differences

    Archives of Gerontology and Geriatrics, Vol. 117

  3. Efficient clinical decision-making process via AI-based multimodal data fusion: A COVID-19 case study

    Heliyon, Vol. 10, Núm. 20

  4. PCSK9 inhibitors on the management of primary and secondary cardiovascular prevention

    Lipids in Health and Disease , Vol. 23, Núm. 1

2023

  1. Impact of days elapsed from the onset of symptoms to hospitalization in COVID-19 in-hospital mortality: Time matters

    Revista Clinica Espanola, Vol. 223, Núm. 5, pp. 281-297

  2. Impact of physician's perception about LDL cholesterol control in clinical practice when treating patients in Spain

    Atherosclerosis, Vol. 375, pp. 38-44

  3. Nosocomial COVID-19: A Nationwide Spanish Study

    Gerontology, Vol. 69, Núm. 6, pp. 671-683

  4. The interaction between liver cirrhosis, infection by Streptococcus bovis, and colon cancer

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 42, Núm. 7, pp. 907-912

2022

  1. 48-Week effectiveness and tolerability of dolutegravir (DTG) + lamivudine (3TC) in antiretroviral-naïve adults living with HIV: A multicenter real-life cohort

    PLoS ONE, Vol. 17, Núm. 11 November

  2. Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: Outcomes and risk factors for graft loss

    American Journal of Transplantation, Vol. 22, Núm. 4, pp. 1169-1181

  3. Analysis of the costs associated with the follow-up of HIV patients discontinuing antiretroviral treatment due to lack of effectiveness or unacceptable toxicity in Spain

    Farmacia Hospitalaria, Vol. 46, Núm. 6, pp. 327-334

  4. Aspergillus endocarditis in the recent years, report of cases of a multicentric national cohort and literature review

    Mycoses, Vol. 65, Núm. 3, pp. 362-373

  5. Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension (Scientific Reports, (2022), 12, 1, (5289), 10.1038/s41598-022-09353-z)

    Scientific Reports

  6. Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

    npj Genomic Medicine, Vol. 7, Núm. 1

  7. Consensus on prevention and treatment of cancer-associated thrombosis (CAT) in controversial clinical situations with low levels of evidence

    European Journal of Internal Medicine, Vol. 100, pp. 33-45

  8. Dalbavancin in clinical practice in Spain: A 2 year retrospective study

    JAC-Antimicrobial Resistance, Vol. 4, Núm. 6

  9. Description of multimorbidity clusters of admitted patients in medical departments of a general hospital

    Postgraduate Medical Journal, Vol. 98, Núm. 1158, pp. 294-299

  10. Differences in clinical features and mortality in very old unvaccinated patients (≥ 80 years) hospitalized with COVID-19 during the first and successive waves from the multicenter SEMI-COVID-19 Registry (Spain)

    BMC Geriatrics, Vol. 22, Núm. 1

  11. Discontinuation due to neuropsychiatric adverse events with efavirenz-and dolutegravir-based antiretroviral therapy: a comparative real-life study

    European Journal of Hospital Pharmacy, Vol. 29, Núm. 4, pp. 207-211

  12. Dyslipidemia observatory: Treatment of hypercholesterolemia in Spain, context and levers for improvement in clinical practice

    Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 5, pp. 253-260